StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
3091.T$4160.00-0.60%
Fair $4160.00+0.0%

3091.T

BRONCO BILLY Co.,LTD.

Consumer Cyclical / RestaurantsTokyo

$4160.00

-25.00 (-0.60%)

Fairly Valued+0.0%Fair Value $4160.00Fund rank 37/100 · Data gapFallback financials|
SA 58/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $1.5B · quality 78.3/100

Data gap 37/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 75/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

58/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 3091.TLocal privado en este navegador · BRONCO BILLY Co.,LTD.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$61.9B

P/E

31.5x

↑

EV/EBITDA

14.4x

↑

ROE

9.1%

↑

Gross Margin

67.2%

↑

Debt/Equity

0.02

↓
52-Week Range$4160
$3385$4780

TradingView lightweight chart

3091.T price, volumen y niveles de valoración

Último $4,160Periodo +1080.1%
Fair value: $4,160

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+15.7%

FCF CAGR

+50.3%

FCF margin

6.4%

FCF / Net income

0.98x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $30.22B · net income $1.97B · FCF $1.93B

2022-FY → 2025-FY

Gross margin

67.2%-0.1% pts

Operating margin

9.7%+5.9% pts

Net margin

6.5%+3.0% pts

FCF margin

6.4%+3.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$30.22B$30.22B$26.62B$23.38B$19.51B
Net Income$1.97B$1.97B$1.72B$1.00B$687.1M
EBITDA$3.70B$3.70B$3.29B$2.33B$1.86B
EPS——115.0867.3346.04
Gross Margin67.2%67.2%67.6%65.5%67.3%
Operating Margin9.7%9.7%9.5%7.0%3.8%
Net Margin6.5%6.5%6.4%4.3%3.5%
Balance Sheet
Debt/Equity0.020.020.020.020.05
Current Ratio2.862.86———
Cash Flow
Free Cash Flow$1.93B$1.93B$1.52B$1.47B$567.9M
Returns
ROE9.1%9.1%8.5%5.4%3.8%
Valuation
P/E31.4631.4631.7247.1652.11
EV/EBITDA14.4314.4314.3717.2516.07
P/B2.852.852.712.542.00
Growth & Yield
Revenue Growth13.5%13.5%13.9%19.8%—
EPS Growth——70.9%46.2%—
Dividend Yield0.7%0.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +19.2%

Total return

+19.2%

Start / end P/E

n/dx → n/dx

EPS bridge

115.08 → n/d

Residual

+18.5%

EPS growthn/d
Multiple reratingn/d
Dividend+0.7%
Residual / FX / buybacks / cross-term+18.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.